WilmerHale Partner Andre Owens Joins LUNGevity Foundation's Board of Directors

WilmerHale Partner Andre Owens Joins LUNGevity Foundation's Board of Directors

Firm News

This press release was prepared and disseminated by the LUNGevity Foundation.

LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced that Andre Owens, partner in the Washington, D.C., law office of WilmerHale, has joined the Board of Directors. Together with other global leaders on the Board, Owens will lend his expertise to further LUNGevity's work of changing outcomes for people with lung cancer.

"We are grateful to have someone as uniquely qualified as Andre join our Board," said Andrea Ferris, CEO of LUNGevity Foundation. "His valuable specialized knowledge coupled with a strong personal motivation for increasing survivorship in lung cancer makes Andre a great addition to help steer the Foundation's research, education, support, and public policy programs."

"Like so many others, I have been personally affected by the loss of loved ones to lung cancer," explains Owens. "While there has been some progress in the lung cancer space, we still have a lot more to do. I am proud and honored to help LUNGevity achieve its vision of creating a world where no one dies of lung cancer." 

Andre's legal practice focuses on securities trading and markets activities. He counsels broker-dealers, securities exchanges, investment advisers, and other clients on a variety of regulatory issues. 

In the past, Andre served as a member of the U.S. Securities and Exchange Commission's Office of General Counsel.  He also served as counsel to former SEC Commissioner Steven M. H. Wallman.

Mr. Owens graduated from Providence College with a bachelor's degree and holds a JD degree from Harvard Law School.

Learn more about the LUNGevity Foundation.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.